Occurrence of blaNDM-7 within IncX3-type plasmid of Escherichia coli from India

Journal of Infection and Chemotherapy

Volumn 23, Issue 4, 2017, Pages 206-210

  Paul, Deepjyoti ^a   Bhattacharjee, Amitabha ^a   Ingti, Birson ^a   Choudhury, Nargis Alom ^a   Maurya, Anand Prakash ^a   Dhar, Debadatta ^b   Chakravarty, Atanu ^b  

^a ASSAM UNIVERSITY   (India)

^b SILCHAR MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

blaNDM 7; Carbapenemase; Escherichia coli; IncX3

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; FROPENEM; GENTAMICIN; IMIPENEM; KANAMYCIN; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; NEW DELHI METALLO BETA LACTAMASE 7; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TIGECYCLINE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BETA LACTAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ADULT; AGED; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; ESCHERICHIA COLI; FEMALE; GENETIC ANALYSIS; GENETIC BACKGROUND; HUMAN; INCX3 GENE; INDIA; MALE; MIDDLE AGED; PLASMID; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; BACTERIUM CONJUGATION; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; GENETICS; MICROBIOLOGY;

BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; CARBAPENEMS; CONJUGATION, GENETIC; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INDIA; PLASMIDS;

EID: 85010602992     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2016.12.009     Document Type: Article

References (18)

1. [1] Wang, L.H., Liu, P.P., Wei, D.D., Liu, Y., Wan, L.G., Xiang, T.X., et al. Clinical isolates of uropathogenic Escherichia coli ST131 producing NDM-7 metallo-β-lactamase in China. Int J Antimicrob Agents, 2016, 10.1016/j.ijantimicag.2016.03.009.
2. [2] Cuzon, G., Bonnin, R.A., Nordmann, P., First identification of novel NDM carbapenemase, NDM-7, in Escherichia coli in France. PLoS One, 8, 2013, e6132, 10.1371/journal.pone.0061322.
3. [3] Gottig, S., Hamprecht, A.G., Christ, S., Kempf, V.A.J., Wichelhaus, T.A., Detection of NDM-7 in Germany, a new variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity. J Antimicrob Chemother 68 (2013), 1737–1740.
4. [4] Rahman, M., Shukla, S.K., Prasad, K.N., Ovejero, C.M., Pati, B.K., Tripathi, A., et al. Prevalence and molecular characterization of New Delhi metallo-β-lactamase NDM-1, NDM-5, NDM-6 and NDM-7 in multidrug resistant enterobacteriaceae from India. Int J Antimicrob Agents 44 (2014), 30–37.
5. NDM-1 in clinical isolates of Pseudomonas aeruginosa associated with hospital infections from India. PLoS One, 10, 2015, e0145823, 10.1371/journal.pone.0145823.
6. NDM-1 in clinical isolates of Pseudomonas aeruginosa from India. Ann Clin Microbiol Antimicrob, 15, 2016, 31, 10.1186/s12941-016-0146-0.
7. [7] Singtohin, S., Chanawong, A., Lulitanond, A., Sribenjalux, P., Auncharoen, A., Kaewkes, W., et al. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand. Diagn Microbiol Infect Dis 68 (2010), 271–277.
8. [8] Clinical Laboratory Standard Institute, Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement, 2011, CLSI, Wayne, USA M100–S21.
9. [9] The European Committee on Antimicrobial Susceptibility Testing, Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0, 2016 http://www.eucast.org.
10. [10] Johnson, T.J., Bielak, E.M., Fortini, D., Hansen, L.H., Hasman, H., Debroy, C., et al. Expansion of the IncX plasmid family for improved identification and typing of novel plasmids in drug resistant enterobacteriaceae. Plasmid 68 (2012), 43–50.
11. NDM-1 positive enterobacteriaceae. Antimicrob Agents Chemother 55 (2011), 5403–5407.
12. NDM among nosocomial isolates of Acinetobacter baumannii from a tertiary referral hospital in northern India. Int J Antimicrob Agents 41 (2013), 452–456.
13. [13] Swick, M.C., Morgan-Linnell, S.K., Carlson, K.M., Zechiedrich, L., Expression of multidrug efflux pump genes acrAB-tolC, mdfA and norE in Escherichia coli clinical isolates as a function of fluroquinolone and multidrug resistance. Antimicrob Agents Chemother 55 (2011), 921–924.
14. NDM-1 in Manila, Philippines. Microb Drug Resist 22 (2016), 585–588.
15. [15] Seara, N., Oteo, J., Carrillo, R., Perez-Blanco, V., Mingorance, J., Gomez-Gil, R., et al. Interhospital spread of NDM-7 producing Klebsiella pneumoniae belonging to ST437 in Spain. Int J Antimicrob Agents 46 (2015), 169–173.
16. [16] Mee-Marquet, N., Diene, S.M., Chopin, F., Goudeau, A., François, P., Enigmatic occurrence of NDM-7 enzyme in the community. Int J Antimicrob Agents, 2016, 10.1016/j.ijantimicag.2016.04.002.
17. [17] Huang, T.W., Chen, T.L., Chen, Y.T., Lauderdale, T.L., Liao, T.L., Lee, Y.T., et al. Copy number change of the NDM-1 sequence in a multidrug–resistant Klebsiella pneumoniae clinical isolate. PLoS One, 8, 2013, e62774, 10.1371/journal.pone.0062774.
18. NDM-7 in Enterobacteriaceae from Calgary, Canada. Antimicrob Agents Chemother 60 (2015), 1258–1263.